Autophagy is an endogenous tightly regulated process responsible for the degradation of damaged and dysfunctional cellular organelles and protein aggregates. Emerging data indicate a strong and complex interaction among autophagy, apoptosis and necrosis. We studied these interactions in a neonatal model of hypoxia-ischemia (HI). Autophagy was assessed by evaluating the expression of the two autophagy proteins beclin 1 and LC3, and by "in vivo" autophagic vesicles formation and clearance using monodansylcadaverine (MDC). Both autophagy and apoptosis pathways were increased in the same neurons at short times after HI. Neuroprotective drugs also increased autophagy. Interestingly, pharmacological inhibition of autophagy switched cell death phenotypes from apoptosis to necrosis. Rapamycin, that enhances autophagy by inhibition of mTOR and previously shown to be neuroprotective in our animal model of HI when administered before the ischemic insult, was used to study the potential interaction between autophagy and survival pathways. Rapamycin, besides inducing autophagy, also increased Akt and CREB (cAMP response element-binding protein) phosphorylation in the same cells. The pharmacological inhibition of the phosphatidylinositol 3-kinase (PI3K)/Akt axis reduced the neuroprotective effect of rapamycin without affecting autophagy. Conversely, pharmacological inhibition of autophagy reduced the neuroprotective effect of rapamycin without affecting Akt phosphorylation. Both treatments, however, caused a rapid switch towards necrotic cell death. Thus, autophagy can be part of an integrated pro-survival signalling which includes the PI3K-Akt- mTOR axis and its activation seems be crucial for pharmacological and ischemic preconditioning.

Balduini, W., Carloni, S., Buonocore, G. (2012). Autophagy in hypoxia-ischemia induced brain injury. THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 25(Supplemento 1), 30-34 [10.3109/14767058.2012.663176].

Autophagy in hypoxia-ischemia induced brain injury

Buonocore, G.
2012-01-01

Abstract

Autophagy is an endogenous tightly regulated process responsible for the degradation of damaged and dysfunctional cellular organelles and protein aggregates. Emerging data indicate a strong and complex interaction among autophagy, apoptosis and necrosis. We studied these interactions in a neonatal model of hypoxia-ischemia (HI). Autophagy was assessed by evaluating the expression of the two autophagy proteins beclin 1 and LC3, and by "in vivo" autophagic vesicles formation and clearance using monodansylcadaverine (MDC). Both autophagy and apoptosis pathways were increased in the same neurons at short times after HI. Neuroprotective drugs also increased autophagy. Interestingly, pharmacological inhibition of autophagy switched cell death phenotypes from apoptosis to necrosis. Rapamycin, that enhances autophagy by inhibition of mTOR and previously shown to be neuroprotective in our animal model of HI when administered before the ischemic insult, was used to study the potential interaction between autophagy and survival pathways. Rapamycin, besides inducing autophagy, also increased Akt and CREB (cAMP response element-binding protein) phosphorylation in the same cells. The pharmacological inhibition of the phosphatidylinositol 3-kinase (PI3K)/Akt axis reduced the neuroprotective effect of rapamycin without affecting autophagy. Conversely, pharmacological inhibition of autophagy reduced the neuroprotective effect of rapamycin without affecting Akt phosphorylation. Both treatments, however, caused a rapid switch towards necrotic cell death. Thus, autophagy can be part of an integrated pro-survival signalling which includes the PI3K-Akt- mTOR axis and its activation seems be crucial for pharmacological and ischemic preconditioning.
2012
Balduini, W., Carloni, S., Buonocore, G. (2012). Autophagy in hypoxia-ischemia induced brain injury. THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 25(Supplemento 1), 30-34 [10.3109/14767058.2012.663176].
File in questo prodotto:
File Dimensione Formato  
2012 Autophagy in hypoxia-ischemia induced brain injury.pdf

non disponibili

Descrizione: Articolo originale
Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 256.32 kB
Formato Adobe PDF
256.32 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/28802
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo